Search Count: 610
All
Selected
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate, Thiocyanate And Factor X Derived Peptide Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, FE, PEG, SCN |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Mn, 2Og, Thiocyanate And Factor X Peptide Fragment (39Mer-4Ser)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, ACT, PEG, MN, SCN |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2Og, Sin And Hydroxylated Product Of Factor X Peptide Fragment (39Mer-4Ser)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: SIN, AKG, FE |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate And Factor X Derived Peptide Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, PEG, CL, FE |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate, Succinate And The Hudroxylated Product Of Factor X Derived Peptide Fragment After O2 Exposure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, SIN, PEG, FE, GOL, CL |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate And A Factor X Derived Peptide Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, PEG, GOL, FE |
 |
Room Temperature Structure Of Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate And Factor X Derived Peptide Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, FE |
 |
Room Temperature Structure Of Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate And Hydroxylated Factor X Derived Peptide Fragment, 2 H O2 Exposure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: SIN, FE |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate, Succinate And The Hydroxylated Product Of Factor X Derived Peptide Fragment, 12 H O2 Exposure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: SIN, FE |
 |
Room Temperature Structure Of Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate, And Hydroxylated Factor X Derived Peptide Fragment, 1.5 S O2 Exposure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, SIN, FE |
 |
Room Temperature Structure Of Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2-Oxoglutarate And Factor X Derived Peptide Fragment, Excess Fe Removed
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE Ligands: AKG, FE |
 |
Aspartyl/Asparaginyl Beta-Hydroxylase (Asph) In Complex With Fe, 2Og, Nitric Oxide, And Factor X Peptide Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2025-12-24 Classification: OXIDOREDUCTASE |
 |
Factor Inhibiting Hif (Fih) In Complex With Manganese And 3-Hydroxy-5-(3-(4-(Hydroxymethyl)-3-Nitrophenyl)Isoxazol-5-Yl)Picolinoyl)Glycine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-05-21 Classification: OXIDOREDUCTASE Ligands: MN, A1IZ5 |
 |
Factor Inhibiting Hif-1 Alpha In Complex With Zn(Ii) And 2-(4-Hydroxy-2-Oxo-1-(Thiazol-4-Ylmethoxy)-1,2-Dihydroquinoline-3-Carboxamido)-2-Methylpropanoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2025-04-30 Classification: OXIDOREDUCTASE Ligands: SO4, A1L4V, ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-01-29 Classification: OXIDOREDUCTASE Ligands: MN, A1IF7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-01-29 Classification: OXIDOREDUCTASE Ligands: SO4, A1L2L, ZN |
 |
Factor Inhibiting Hif-1 Alpha In Complex With (5-(1-(3-(4-Chlorophenyl)Propyl)-1H-1,2,3-Triazol-4-Yl)-3-Hydroxypicolinoyl)Glycine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.22 Å Release Date: 2024-02-28 Classification: OXIDOREDUCTASE Ligands: SO4, ZN, P1X |
 |
Factor Inhibiting Hif-1 Alpha In Complex With (5-(3-(3-Chlorophenyl)Isoxazol-5-Yl)-3-Hydroxypicolinoyl)Glycine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2024-02-28 Classification: OXIDOREDUCTASE Ligands: P5I, GOL, ZN, SO4 |
 |
Factor-Inhibiting Hypoxia-Inducible Factor In Complex With Zn(Ii) And 2-(3-Hydroxy-2-((2-((Naphthalen-2-Ylmethyl)Sulfonyl)Acetyl)Imino)-2,3-Dihydrothiazol-4-Yl)Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2023-12-13 Classification: OXIDOREDUCTASE Ligands: ZN, VIZ, SO4, GOL |
 |
Factor-Inhibiting Hypoxia-Inducible Factor In Complex With Zn(Ii) And 2-(3-Hydroxy-2-((3-(Phenylsulfonamido)Propanoyl)Imino)-2,3-Dihydrothiazol-4-Yl)Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-12-13 Classification: OXIDOREDUCTASE Ligands: SO4, GOL, ZN, VJF |